Biofrontera Inc. (BFRI) vs Tempest Therapeutics, Inc. (TPST)

A side-by-side comparison of Biofrontera Inc. and Tempest Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Biofrontera Inc. logo
BFRI
Biofrontera Inc.
$12M
$0.93HealthcareDelayed quote: Oct 6, 2026, 3:03 PM EDT
Tempest Therapeutics, Inc. logo
TPST
Tempest Therapeutics, Inc.
$12M
$0.78HealthcareDelayed quote: Oct 6, 2026, 2:57 PM EDT

Total return — BFRI vs TPST

growth of $100 · dividends reinvested · last 5y
BFRI -99.0% (-60.1%/yr)TPST -99.5% (-65.3%/yr)BFRI compounded faster over this window
0100200300Start $10020222023202420252026$1$1
BFRI TPST

BFRI vs TPST: by the numbers

  • •TPST is the larger company ($12M vs $12M market cap).
  • •Both run net losses; TPST's is the smaller (0.00% vs -13.78% net margin).

Metrics side by side

Valuation

MetricBFRITPST
P/S ratio0.26N/A
P/B ratio2.00N/A

Profitability

MetricBFRITPST
Gross margin84.45%0.00%
Operating margin-21.94%0.00%
Net margin-13.78%0.00%
ROE-106.87%N/A
ROIC-32.27%-784.16%

Growth (annualized)

MetricBFRITPST
Revenue CAGR (5Y)15.55%N/A
Total return CAGR (5Y)N/A-66.75%

Go deeper

Full BFRI analysisFull TPST analysisInteractive comparison tool

Dig into the metrics

Biofrontera ROETempest Therapeutics ROEBiofrontera operating marginTempest Therapeutics operating marginBiofrontera revenue growthTempest Therapeutics revenue growthBiofrontera free cash flowTempest Therapeutics free cash flow

Biofrontera & Tempest Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.